Optimised CD33 (FL-33) CAR T Therapy

· Beijing GoBroad Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Optimised CD33 (FL-33) CAR T Therapy, covering 2026-03-10 to 2026-03-10. Get the full timeline:

Most recent: Clinical Trial Update: Optimised CD33 (FL-33) CAR T Therapy for Refractory/Relapsed Acute Myeloid Leukaemia [Phase 1]